- Home
- ESEA vs GNFT Comparison
ESEA vs GNFT Comparison
Compare ESEA & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- GNFT
- Stock Information
- Founded
- ESEA 2005
- GNFT 1999
- Country
- ESEA Greece
- GNFT France
- Employees
- ESEA N/A
- GNFT N/A
- Industry
- ESEA Marine Transportation
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESEA Consumer Discretionary
- GNFT Health Care
- Exchange
- ESEA Nasdaq
- GNFT Nasdaq
- Market Cap
- ESEA 208.2M
- GNFT 186.3M
- IPO Year
- ESEA 2006
- GNFT 2019
- Fundamental
- Price
- ESEA $48.62
- GNFT $3.75
- Analyst Decision
- ESEA Strong Buy
- GNFT Strong Buy
- Analyst Count
- ESEA 1
- GNFT 1
- Target Price
- ESEA $62.00
- GNFT $13.00
- AVG Volume (30 Days)
- ESEA 50.8K
- GNFT 3.8K
- Earning Date
- ESEA 08-05-2025
- GNFT 04-24-2025
- Dividend Yield
- ESEA 5.33%
- GNFT N/A
- EPS Growth
- ESEA 21.86
- GNFT N/A
- EPS
- ESEA 18.62
- GNFT 0.03
- Revenue
- ESEA $222,525,034.00
- GNFT $73,187,701.00
- Revenue This Year
- ESEA $5.14
- GNFT $15.98
- Revenue Next Year
- ESEA $3.76
- GNFT N/A
- P/E Ratio
- ESEA $2.54
- GNFT $120.71
- Revenue Growth
- ESEA 14.62
- GNFT 105.01
- 52 Week Low
- ESEA $24.58
- GNFT $2.55
- 52 Week High
- ESEA $50.82
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- ESEA 61.35
- GNFT 44.52
- Support Level
- ESEA $46.59
- GNFT $3.44
- Resistance Level
- ESEA $50.50
- GNFT $3.81
- Average True Range (ATR)
- ESEA 1.84
- GNFT 0.17
- MACD
- ESEA -0.13
- GNFT -0.00
- Stochastic Oscillator
- ESEA 53.62
- GNFT 56.65
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.